NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 107 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.00 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,605,000 | -2.9% | 364,800 | +1.2% | 0.23% | -0.4% |
| Q4 2020 | $10,921,000 | +90.4% | 360,500 | +0.0% | 0.23% | +58.9% |
| Q3 2020 | $5,735,000 | -18.7% | 360,454 | +0.9% | 0.15% | -24.7% |
| Q2 2020 | $7,055,000 | +63.0% | 357,409 | +1.8% | 0.19% | +8.4% |
| Q1 2020 | $4,329,000 | -33.3% | 351,100 | 0.0% | 0.18% | -12.7% |
| Q4 2019 | $6,492,000 | +33.5% | 351,100 | 0.0% | 0.20% | +5.7% |
| Q3 2019 | $4,863,000 | -5.4% | 351,100 | 0.0% | 0.19% | +4.3% |
| Q2 2019 | $5,140,000 | – | 351,100 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |